VenoStent Enrolls First Subjects in 200-Subject US Clinical Trial
VenoStent is conducting a 200-subject, prospective, one-to-one randomized controlled trial in dialysis accessHOUSTON, TX / ACCESSWIRE / January 30, 2024 / VenoStent, Inc., a clinical-stage, venture-backed, therapeutic medical device company developing …